FDA lifts hold on studies testing Cell Therapeutics' cancer drug

(Reuters) - Cell Therapeutics Inc said the U.S. Food and Drug Administration lifted a hold imposed in June last year on studies testing the company's blood cancer drug. The company's shares rose about 3 percent to $1.97 in premarket trading on Thursday. Cell Therapeutics said it received the notification from the regulator on December 26. The FDA placed the hold after a patient treated with a combination of the drug, tosedostat, and a chemotherapy drug died of a heart muscle infection.



via Health News Headlines - Yahoo News http://news.yahoo.com/fda-lifts-hold-studies-testing-cell-therapeutics-39-123258554--finance.html